2020
DOI: 10.3389/fgene.2020.578345
|View full text |Cite
|
Sign up to set email alerts
|

Integration of Online Omics-Data Resources for Cancer Research

Abstract: The manifestations of cancerous phenotypes necessitate alterations at different levels of information-flow from genome to proteome. The molecular alterations at different information processing levels serve as the basis for the cancer phenotype to emerge. To understand the underlying mechanisms that drive the acquisition of cancer hallmarks it is required to interrogate cancer cells using multiple levels of information flow represented by different omics-such as genomics, epigenomics, transcriptomics, and prot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(31 citation statements)
references
References 78 publications
(107 reference statements)
0
30
0
1
Order By: Relevance
“…For those interested in greater details, they are encouraged to visit the sites listed or read a number of excellent reviews on databases for accessing and analyzing multi‐omic datasets. [ 110–115 ]…”
Section: Integrating Omicsmentioning
confidence: 99%
“…For those interested in greater details, they are encouraged to visit the sites listed or read a number of excellent reviews on databases for accessing and analyzing multi‐omic datasets. [ 110–115 ]…”
Section: Integrating Omicsmentioning
confidence: 99%
“…Bioinformatics plays a central role in the downstream analysis of the large body of proteomics data that is currently being generated, and as such it is one of the 4 HUPO resource pillars [ 11 ]. A number of iterative bioinformatic tools and web servers have been developed to assist in this analysis [ 84 , 85 ], some targeted specifically for cancer (e.g., Perseus [ 86 ] and the Cancer Genome Atlas (TCGA) [ 87 ]).…”
Section: Proteomics the Current Statusmentioning
confidence: 99%
“…Single-cell RNA sequencing technology is especially suitable to patient-derived organoids because it preserves the heterogeneity of the cells (Camp and Treutlein, 2017;Camp et al, 2018). Single-cell level analysis spans not only transcriptome sequencing but also whole-genome, proteome, and metabolome analysis (Irish et al, 2006;Restrepo-Pérez et al, 2018;Das et al, 2020;Xing et al, 2020;Specht et al, 2021). These single-cell level multi-omics analyses have good compatibility with organoid technology.…”
Section: Other Useful Technologiesmentioning
confidence: 99%